Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease.
about
HIV Associated Neurocognitive DisordersCrystal Structure of NFAT Bound to the HIV-1 LTR Tandem κB Enhancer ElementAcetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.Equine infectious anemia virus is found in tissue macrophages during subclinical infectionTissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equidsQuantitative molecular analysis of virus expression and replication.Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patientsCellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts.Presence of neutralizing antibodies to heterologous human immunodeficiency virus type 1 isolates in sera of infected individuals is not predictive of rate of disease progressionClinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.Comparison of the effects of 3'-azidothymidine with those of neutralizing antibodies on simian immunodeficiency virus infection in macrophages.Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort.Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individualsHigh levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivoEvolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function.Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes.Mapping the determinants of human immunodeficiency virus 2 for infectivity, replication efficiency, and cytopathicity.Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds.Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assayNegative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat.Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2.Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo.Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities.Uses of flow cytometry in virologyHigh viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees.Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.Cell-associated HIV RNA: a dynamic biomarker of viral persistence.Standardized nested polymerase chain reaction-based assay for detection of human immunodeficiency virus type 1 DNA in whole blood lysates.Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction.Peripheral blood mononuclear cell human immunodeficiency virus type 1 proviral DNA quantification by polymerase chain reaction: relationship to immunodeficiency and drug effect.Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reactionBlocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection.Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytesMolecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1.Use of multiple competitors for quantification of human immunodeficiency virus type 1 RNA in plasma.Comparison of an amplified enzyme-linked immunosorbent assay with procedures based on molecular biology for assessing human immunodeficiency virus type 1 viral load
P2860
Q27023968-274BAE06-7933-47E9-8461-AAD0E9296B89Q27650549-F9849A96-8AF3-4341-9E86-995520FD3A5DQ33236503-1F11C9D7-4F2D-4AD5-82BB-815F3C2FFF4BQ33783820-91244F7B-395F-479C-A845-4064B0903E83Q33801103-10BD17C0-41B0-4756-9A47-5D4051ABB780Q33931554-9C70EF06-9464-4D71-B4C4-3A34986AE9E5Q34742090-D7E3A164-EFCD-4B4F-8130-F3A1971E9883Q35202038-4C5F2797-458D-46E5-ABEE-99F00C4CCA3FQ35224610-B9173900-B6FD-45E6-97A6-8ECFF7E4F279Q35369891-D23A5AEC-3B88-4F88-8B83-A0140433ABBDQ35809341-D531D8FF-AEF5-404F-9286-3E089ACACD57Q35835327-BEF9C289-BFFD-422D-852D-699F6872785AQ35837198-947477DB-AEAE-450C-B2C3-0E41626DF4DEQ35846166-61D7DEF9-220F-4EB6-86D0-DB9279255FFCQ35861490-79DD5722-88F8-4FFF-973E-4BC6F0388167Q35871860-40060A02-927B-4068-BAAC-BC9F9771A99EQ35877849-4E890F71-4BB2-4FF1-9015-1C53C1BD054FQ36063873-F3613977-A453-45BB-BC3B-D6B6EF3503FDQ36287468-613FA736-46E1-4AB7-9C99-1AF238089E26Q36516929-CDDE2451-EC45-4BD1-9C8C-5017058734F4Q36523010-9CB5AD26-A8A7-438E-A5F0-F9084DB07D1DQ36627016-E39B1A57-5E10-4ECA-8F71-2ECBCF8D7BD9Q36630643-CB95ADAC-DBF3-4766-AB80-755ECF5212C7Q36632350-F1E05854-232E-4EFC-AE82-2892CC111874Q36633545-ED62E159-8F17-47CD-A63C-9C4F41969DF5Q36642143-8769A437-0C8F-4CE7-ACD6-E48CB8F226B8Q36655355-DB2F98F6-E470-4C16-B066-4A432AEA7693Q36685254-38E60E4D-0600-4C8B-B1C4-331443C1F6EEQ36687307-06506BF8-B1EB-423B-83DA-95A13D55FC08Q36798408-C57F87E7-77DC-4739-AAB4-64494F5CDF81Q37067358-55C66795-D3D4-4F86-9156-56E450E07301Q37131155-72EE4526-6B86-41BE-B4C0-7DCF1DB7E772Q37138126-9C057487-6312-4874-A952-844E7E9E434EQ37141864-475B0F46-EF06-4331-B309-2BBB7D2E3AA9Q37292229-27B9220E-9843-4D2D-A62F-5E3CE8D53060Q37371274-1B945D2B-B8F7-4B15-85A3-392081969F75Q37558815-E29B2AE2-9D47-4A10-84C0-69C5B00F9AA7Q38296043-5E7269EE-15DD-422F-A07D-D45B2C2218F8Q38335902-2E8CB5DB-F20D-4FB7-960B-A72F43FAFFD4Q39505835-116312DC-C159-442F-BEFB-0C2A5F2C0646
P2860
Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Viral DNA and mRNA expression ...... in all stages of HIV disease.
@en
type
label
Viral DNA and mRNA expression ...... in all stages of HIV disease.
@en
prefLabel
Viral DNA and mRNA expression ...... in all stages of HIV disease.
@en
P2093
P2860
P1433
P1476
Viral DNA and mRNA expression ...... in all stages of HIV disease.
@en
P2093
P2860
P304
P407
P577
1992-01-01T00:00:00Z